The Pharmaceutical Supply Chain
Gross Drug Expenditures Realized by Stakeholders
Within the US healthcare system, the flow of dollars in the pharmaceutical marketplace is a complex process involving a variety of stakeholders and myriad rebates, discounts, and fees—some of which are paid after a prescription drug is dispensed to the patient.
In this study, Aaron Vandervelde and Eleanor Blalock discuss the drug distribution and payment process and estimate the share of gross and net drug expenditures realized by manufacturers and other entities along the supply chain.
Read the January 2020 update.
This study was funded by the Pharmaceutical Research and Manufacturers of America.